CClinicalTrials.gg
WithdrawnNCT03358095Updated May 20, 2021

Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?

An interventional study of Tannenbaum Fr 10 stent or WallFlex stent in Pancreatic Cancer and Biliary Stasis, sponsored by Helsinki University Central Hospital. Withdrawn at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-20.

Sponsored by Helsinki University Central Hospital · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Investigators busy with other projects at the moment.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Surgical resection is the only option for cure for patients with a resectable tumor located at the head of the pancreas. At the time of diagnosis, these patients often suffer from jaundice. Studies have suggested, that jaundice might increase the risk of developing a serious postoperative complication. Preoperative biliary drainage is widely used, because it is considered to improve the surgical outcome and reduce the amount of postoperative complications. There are also studies that suggest the opposite. In these studies the overall complication rate with patients who underwent preoperative biliary drainage was higher than in the patients who were operated right away. A significant amount of these complications were related to the biliary drainage process itself. However, preoperative biliary decompression is widely used in many centers as many surgical centers don't possess the needed resources to arrange early surgery. The benefits and risks of this procedure remain unclear. This multicenter trial aims to compare the surgical outcome and the rate of serious complications in patients who proceed directly to early surgery and patients who have preoperative biliary drainage.

02

Conditions studied

  • Pancreatic Cancer
  • Biliary Stasis
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients in this study must have a resectable tumor of the head of the pancreas, and no evidence of distant metastasis or local vascular involvement. At the beginning of the study it's not necessary to have an accurate histologic diagnosis, the tumor might be malignant or benign. The patients also have jaundice with a total serum bilirubin level of 40-250µmol/l, and are fit enough to be considered for an early surgery.

Exclusion criteria

Exclusion Criteria:

  • Patients with ongoing cholangitis, neoadjuvant treatments or previous biliary drainage with stenting by means of ERCP or PTC (Percutaneous Transhepatic Cholangiogram) are excluded.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Early surgery

    Patients in this group proceed to pancreatic resection within 2 week of recruitment.

  • Active comparator
    Preoperative biliary drainage

    Endoscopic retrograde cholangiopancreatography (ERCP) is used to place an endoprosthesis to the biliary ducts to drain biliary stasis, and the patients proceed to pancreatic resection within 6 weeks of recruitment.

    Device: Tannenbaum Fr 10 stent or WallFlex stent

Interventions

  • DeviceTannenbaum Fr 10 stent or WallFlex stent

    A plastic or metallic endoprosthesis is placed to the biliary ducts.

05

What researchers measure

Primary outcomes

  1. Emerged complications related to surgery or preoperative endoscopy within 120 days of surgery

    Time frame: 120 days after surgery

06

Study locations

1 site
  • Helsinki University Hospital
    Helsinki, Uusimaa 00029, Finland
07

References and documents

Publications

  • van der Gaag NA, Kloek JJ, de Castro SM, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg. 2009 Apr;13(4):814-20. doi: 10.1007/s11605-008-0618-4. Epub 2008 Aug 23. PubMed 18726134 ↗
  • van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230. PubMed 20071702 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03358095
Lead sponsor
Helsinki University Central Hospital
Responsible party
Leena Kylanpaa (Head of department, Helsinki University Central Hospital) — Principal investigator
First posted
Nov 30, 2017
Start date
Nov 26, 2017
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 20, 2021

Study contacts

Sini Vehviläinen, MD
study chair · Helsinki University Central Hospital
Hanna Seppänen, MD, PhD
study chair · Helsinki University Central Hospital
Arto Kokkola, MD, PhD
study chair · Helsinki University Central Hospital
Marianne Udd, MD, PhD
study chair · Helsinki University Central Hospital
Outi Lindström, MD, PhD
study chair · Helsinki University Central Hospital
Johanna Louhimo, MD, PhD
study chair · Helsinki University Central Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion